130 related articles for article (PubMed ID: 16534545)
1. Synergistic effects of atorvastatin and sildenafil in cardioprotection--role of NO.
Kukreja RC
Cardiovasc Drugs Ther; 2006 Feb; 20(1):5-8. PubMed ID: 16534545
[No Abstract] [Full Text] [Related]
2. Enhanced cardioprotection against ischemia-reperfusion injury with combining sildenafil with low-dose atorvastatin.
Rosanio S; Ye Y; Atar S; Rahman AM; Freeberg SY; Huang MH; Uretsky BF; Birnbaum Y
Cardiovasc Drugs Ther; 2006 Feb; 20(1):27-36. PubMed ID: 16435070
[TBL] [Abstract][Full Text] [Related]
3. The effects of quinapril and atorvastatin on the responsiveness to sildenafil in men with erectile dysfunction.
Bank AJ; Kelly AS; Kaiser DR; Crawford WW; Waxman B; Schow DA; Billups KL
Vasc Med; 2006 Nov; 11(4):251-7. PubMed ID: 17390549
[TBL] [Abstract][Full Text] [Related]
4. Atorvastatin improves the response to sildenafil in hypercholesterolemic men with erectile dysfunction not initially responsive to sildenafil.
Dadkhah F; Safarinejad MR; Asgari MA; Hosseini SY; Lashay A; Amini E
Int J Impot Res; 2010; 22(1):51-60. PubMed ID: 19865092
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin improves erectile dysfunction in patients initially irresponsive to Sildenafil by the activation of endothelial nitric oxide synthase.
El-Sisi AA; Hegazy SK; Salem KA; AbdElkawy KS
Int J Impot Res; 2013; 25(4):143-8. PubMed ID: 23324897
[TBL] [Abstract][Full Text] [Related]
6. Atorvastatin ameliorates sildenafil-induced penile erections in experimental diabetes by inhibiting diabetes-induced RhoA/Rho-kinase signaling hyperactivation.
Morelli A; Chavalmane AK; Filippi S; Fibbi B; Silvestrini E; Sarchielli E; Zhang XH; Vignozzi L; Vannelli GB; Forti G; Maggi M
J Sex Med; 2009 Jan; 6(1):91-106. PubMed ID: 19170840
[TBL] [Abstract][Full Text] [Related]
7. Sildenafil-mediated acute cardioprotection is independent of the NO/cGMP pathway.
Elrod JW; Greer JJ; Lefer DJ
Am J Physiol Heart Circ Physiol; 2007 Jan; 292(1):H342-7. PubMed ID: 16951048
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandins mediate the cardioprotective effects of atorvastatin against ischemia-reperfusion injury.
Birnbaum Y; Ye Y; Rosanio S; Tavackoli S; Hu ZY; Schwarz ER; Uretsky BF
Cardiovasc Res; 2005 Feb; 65(2):345-55. PubMed ID: 15639473
[TBL] [Abstract][Full Text] [Related]
9. Atorvastatin but not elocalcitol increases sildenafil responsiveness in spontaneously hypertensive rats by regulating the RhoA/ROCK pathway.
Fibbi B; Morelli A; Marini M; Zhang XH; Mancina R; Vignozzi L; Filippi S; Chavalmane A; Silvestrini E; Colli E; Adorini L; Vannelli GB; Maggi M
J Androl; 2008; 29(1):70-84. PubMed ID: 17699803
[TBL] [Abstract][Full Text] [Related]
10. Protection by atorvastatin pretreatment in patients undergoing primary percutaneous coronary intervention is associated with the lower levels of oxygen free radicals.
Chen M; Li H; Wang Y
J Cardiovasc Pharmacol; 2013 Sep; 62(3):320-4. PubMed ID: 23714773
[TBL] [Abstract][Full Text] [Related]
11. Therapy of pulmonary hypertension: targeting pathogenic mechanisms with selective treatment delivery.
Rubin LJ
Crit Care Med; 2001 May; 29(5):1086-7. PubMed ID: 11378627
[No Abstract] [Full Text] [Related]
12. Cardioprotection with phosphodiesterase-5 inhibition--a novel preconditioning strategy.
Kukreja RC; Ockaili R; Salloum F; Yin C; Hawkins J; Das A; Xi L
J Mol Cell Cardiol; 2004 Feb; 36(2):165-73. PubMed ID: 14871543
[TBL] [Abstract][Full Text] [Related]
13. Synergistic protection against vascular inflammation with a calcium channel blocker and a statin.
Hirata Y; Sata M
Hypertens Res; 2011 Apr; 34(4):441-2. PubMed ID: 21270818
[No Abstract] [Full Text] [Related]
14. Cardiovascular protection with sildenafil following chronic inhibition of nitric oxide synthase.
Kukreja RC
Br J Pharmacol; 2007 Mar; 150(5):538-40. PubMed ID: 17245364
[TBL] [Abstract][Full Text] [Related]
15. Sildenafil induces delayed preconditioning through inducible nitric oxide synthase-dependent pathway in mouse heart.
Salloum F; Yin C; Xi L; Kukreja RC
Circ Res; 2003 Apr; 92(6):595-7. PubMed ID: 12637371
[TBL] [Abstract][Full Text] [Related]
16. Atorvastatin for acute coronary syndromes.
Schwartz GG; Olsson AG; Ezekowitz MD; Ganz P; Oliver MF; Waters D; Zeiher A; Chaitman BR
JAMA; 2001 Aug; 286(5):533-5. PubMed ID: 11476650
[No Abstract] [Full Text] [Related]
17. Sildenafil-induced cardioprotection in rabbits.
Kukreja RC; Ockaili R; Salloum F; Xi L
Cardiovasc Res; 2003 Dec; 60(3):700-1; author reply 702-3. PubMed ID: 14659816
[No Abstract] [Full Text] [Related]
18. Atorvastatin in nonischemic left ventricular systolic dysfunction.
Bahl A; Chongtham DS
J Am Coll Cardiol; 2006 Sep; 48(6):1283; author reply 1284. PubMed ID: 16979019
[No Abstract] [Full Text] [Related]
19. Torcetrapib and atorvastatin.
Shear CL
N Engl J Med; 2005 Oct; 353(14):1527-9; author reply 1527-9. PubMed ID: 16207861
[No Abstract] [Full Text] [Related]
20. Sildenafil and cardioprotection.
Kukreja RC
Curr Pharm Des; 2013; 19(39):6842-7. PubMed ID: 23590161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
